首页> 外文OA文献 >Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH)

【2h】

Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH)

机译：Avelumab-cetuximab-放射疗法与患者（PTS）的护理标准（SOC），头部和颈部（LA-SCCHN）：随机试验的安全阶段2017-01（REACH）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Y. Tao; A. Auperin; X. Sun; C. Sire; L. Martin; A. Coutte; C. Lafond; J. Miroir; X. Liem; F. Rolland; A. Maillard; N. Colin-Barailhou; C. Michel; J. Thariat; J. Guigay; J. Bourhis;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 8519 A phase 2, randomized trial (CONCERT-1) of chemoradiotherapy with or without panitumumab in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): Interim pooled safety analysis [J] . A.Fortin, A.Cmelak, R.Mesía, European Journal of Cancer Supplements . 2009,第2期

机译：8519在未切除，局部晚期头颈部鳞状细胞癌（SCCHN）的患者（pts）中接受或不接受panitumumab的放化疗的2期随机试验（CONCERT-1）：中期合并安全性分析
2. Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent. [J] . Tortochaux J, Tao Y, Tournay E, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2011,第1期

机译：随机III期临床试验（GORTEC 98-03）比较了以姑息性治疗方式治疗的复发性或继发性原发性头颈部鳞状细胞癌患者中，再次照射加化疗与甲氨蝶呤的比较。
3. A randomized trial (RAREST-01) comparing Mepitel (R) Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN) [J] . Rades Dirk, Narvaez Carlos A., Splettstosser Laura, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2019,第期

机译：随机试验（RAREST-01）比较梅特尔（R）薄膜和预防辐射皮炎的标准护理，以促进颈部（SCCHN）局部晚期鳞状细胞癌的患者
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma [O] . Junlin Yi, Xiaodong Huang, Zhengang Xu, 2017

机译：局部晚期头颈部鳞状细胞癌患者术前同期放化疗与术前放疗三期随机试验
7. Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial [O] . Yungan Tao, Anne Auperin, Pierre Blanchard, 2020

机译：随着强度调节放疗（IMRT）对局部先进头和颈鳞状细胞癌（HTSCC）的常规放疗（HOREC 2004-01随机阶段III试验，并发顺铂和剂量升级与常规放射治疗

Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH)

著录项

引文网络

相似文献

相关主题

期刊订阅